Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
7507705 | Drug and Alcohol Dependence | 2013 | 6 Pages |
Abstract
These results support and extend previous findings that treatment with methadone in modest doses (i.e. below 100Â mg/d) is not associated with clinically significant QTc increases, and that buprenorphine in commonly used doses is a suitable alternative to methadone with regard to the risk of QTc prolongation.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Marianne Stallvik, Berit Nordstrand, Ãistein Kristensen, Jørn Bathen, Eirik Skogvoll, Olav Spigset,